# Emergent BioSolutions Inc.: Form 8-K, filed Sep 17, 2024

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2024-09-17
- Accepted by EDGAR: Sep 17, 2024, 16:12 ET
- Period: 2024-09-17
- Accession: 0001367644-24-000158
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000158/ebs-20240917.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000158/

## Items reported

- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764424000158/ebs-20240917.htm

Filed Sep 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001367644-24-000158. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.